Macular degeneration trials in China
8 of 37 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
- Where
- Beijing, Hangzhou, Hefei, Shanghai, Wenzhou
- Age
- 50 years and over
- People
- 83 worldwide
- Run by
- Skyline Therapeutics
See details and how to joinNCT06346600 - No phaseTaking peopleReal-world Study of Aflibercept 8 mg in nAMD
- Where
- Beijing, Chengdu, Dalian, Fuzhou, Harbin, Hohhot, Jinan, Nanyang, Ningbo, Qingdao, Shanghai, Shenyang, Shenzhen, Tianjin, Wenzhou, Wuhan, Xi’an, Zunyi
- Age
- 50 years and over
- People
- 300
- Run by
- Peking University People's Hospital
See details and how to joinNCT07640997 - No phaseNot yet taking people in ChinaProspective, Single Arm, Observational Study of Faricimab in the Treatment of Neovascular Age-related Macular Degeneration (nAMD)
- Where
- Guangzhou
- Age
- 50 years and over
- People
- 50
- Run by
- Sun Yat-sen University
See details and how to joinNCT07581782 - No phaseTaking peopleNatural History Study of Inherited Retinal Diseases
- Where
- Wuhan
- People
- 200
- Run by
- Augelux Therapeutics
See details and how to joinNCT07085533 - No phaseTaking peopleA Long-term Follow up Study of EXG102-031 in Participants With wAMD
- Where
- Beijing
- Age
- 50 years and over
- People
- 42
- Run by
- Guangzhou Jiayin Biotech Ltd
See details and how to joinNCT06859515 - No phaseNot yet taking people in ChinaAn Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
- Where
- Guangzhou
- People
- 9,999
- Run by
- Zhongshan Ophthalmic Center, Sun Yat-sen University
See details and how to joinNCT06918028 - No phaseTaking peopleLong-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD
- Where
- Beijing
- Age
- 50 years and over
- People
- 21
- Run by
- Beijing Anlong Biopharmaceutical Co., Ltd.
See details and how to joinNCT06718816 - No phaseNot yet taking people in ChinaObservation of the Natural Course of Age-related Macular Degeneration
- Where
- Shanghai
- Age
- 50 years to 85 years
- People
- 500
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05418231